| Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy LM Mir, LF Glass, G Serša, J Teissie, C Domenge, D Miklavčič, ... British journal of cancer 77 (12), 2336-2342, 1998 | 597 | 1998 |
| Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients G Serša, B Štabuc, M Cemazar, D Miklavcic, Z Rudolf Clinical Cancer Research 6 (3), 863-867, 2000 | 262 | 2000 |
| Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy B Stabuc, L Vrhovec, M Stabuc-Silih, TE Cizej Clinical chemistry 46 (2), 193-197, 2000 | 238 | 2000 |
| Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients G Serša, B Štabuc, M Čemažar, B Jančar, D Miklavčič, Z Rudolf European journal of cancer 34 (8), 1213-1218, 1998 | 204 | 1998 |
| Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of … G Serša, B Štabuc, M Cemažar, D Miklavcic, Z Rudolf Melanoma research 10 (4), 381-385, 2000 | 129 | 2000 |
| Diagnosing cytomegalovirus in patients with inflammatory bowel disease—by immunohistochemistry or polymerase chain reaction? N Zidar, I Ferkolj, K Tepeš, B Štabuc, N Kojc, T Uršič, M Petrovec Virchows Archiv 466, 533-539, 2015 | 68 | 2015 |
| Down‐regulation of microRNAs of the miR‐200 family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal … N Zidar, E Boštjančič, M Jerala, N Kojc, D Drobne, B Štabuc, D Glavač Journal of cellular and molecular medicine 20 (10), 1813-1820, 2016 | 67 | 2016 |
| Effects of a probiotic product containing Bifidobacterium animalis subsp. animalis IM386 and Lactobacillus plantarum MP2026 in lactose intolerant individuals: Randomized … I Roškar, K Švigelj, M Štempelj, J Volfand, B Štabuc, Š Malovrh, I Rogelj Journal of Functional Foods 35, 1-8, 2017 | 59 | 2017 |
| Acute biliary pancreatitis: detection of common bile duct stones with endoscopic ultrasound B Štabuc, D Drobne, I Ferkolj, A Gruden, J Jereb, G Kolar, V Mlinaric, ... European journal of gastroenterology & hepatology 20 (12), 1171-1175, 2008 | 54 | 2008 |
| Peak concentrations of ustekinumab after intravenous induction therapy identify patients with Crohn’s disease likely to achieve endoscopic and biochemical remission J Hanžel, J Zdovc, T Kurent, N Sever, K Javornik, K Tuta, M Koželj, ... Clinical Gastroenterology and Hepatology 19 (1), 111-118. e10, 2021 | 46 | 2021 |
| Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease D Drobne, T Kurent, S Golob, P Švegl, P Rajar, J Hanžel, M Koželj, ... Alimentary Pharmacology & Therapeutics 49 (7), 880-889, 2019 | 44 | 2019 |
| Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients S Markovič, E Gadžijev, B Štabuc, LS Croce, F Masutti, M Šurlan, ... Journal of hepatology 29 (4), 650-659, 1998 | 44 | 1998 |
| Muscle psoas indices measured by ultrasound in cirrhosis—preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality A Hari, A Berzigotti, B Štabuc, N Caglevič Digestive and Liver Disease 51 (11), 1502-1507, 2019 | 40 | 2019 |
| Cathepsin D expression in early cutaneous malignant melanoma I Bartenjev, Z Rudolf, B Štabuc, I Vrhovec, T Perkovič, A Kansky International journal of dermatology 39 (8), 599-602, 2000 | 32 | 2000 |
| Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease J Hanžel, N Sever, I Ferkolj, B Štabuc, N Smrekar, T Kurent, M Koželj, ... United European Gastroenterology Journal 7 (6), 741-749, 2019 | 28 | 2019 |
| Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease G Novak, T Stevens, T Van Viegen, P Bossuyt, B Štabuc, J Jeyarajah, ... Alimentary pharmacology & therapeutics 49 (11), 1401-1409, 2019 | 28 | 2019 |
| A “crossomics” study analysing variability of different components in peripheral blood of healthy caucasoid individuals K Gruden, M Hren, A Herman, A Blejec, T Albrecht, J Selbig, C Bauer, ... PLoS One 7 (1), e28761, 2012 | 26 | 2012 |
| Priporočila za prehransko obravnavo bolnikov v bolnišnicah in starostnikov v domovih za starejše občane O Cerović, I Hren, B Knap, L Kompan, M Lainščak, J Lavrinec, ... Ministrstvo za zdravje, 2008 | 24 | 2008 |
| Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase B Tepeš, B Štabuc, M Stefanovic, M Bracko, SF Grazio, DN Mlakar, ... European journal of cancer prevention 23 (4), 235-239, 2014 | 22 | 2014 |
| Serum values of tumour necrosis factor-α and of soluble tumour necrosis factor-R55 in melanoma patients J Ocvirk, B Štabuc, Z Rudolf, V Galvani, V Curin-Šerbec Melanoma Research 10 (3), 253-258, 2000 | 18 | 2000 |
